Eli Lilly (LLY) PT Raised to $580 at Credit Suisse
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,305.02 +2.70%
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 44
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 44
Join SI Premium – FREE
Credit Suisse analyst Trung Huynh raised the price target on Eli Lilly (NYSE: LLY) to $580.00 (from $490.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Lilly breaks ground on $5B Virginia drug manufacturing facility
- CSX (CSX) PT Raised to $49 at Bernstein SocGen Group
- Meta Platforms Inc. (META) PT Raised to $850 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
